Impact of age-adjusted Insulin-like Growth Factor I on major cardiovascular events after acute myocardial infarction.

CONCLUSIONS: Low IGF-I score is associated with increased risk of all cause-death, recurrent MI and stroke in AMI patients. Whether patients treated by IGF-I axis inhibitors have a specific clinical course after AMI would be worth studying.
PMID: 25699636 [PubMed - as supplied by publisher]

Source: The Journal of Clinical Endocrinology and Metabolism - February 20, 2015 Category: Endocrinology Authors: Bourron O, Le Bouc Y, Berard L, Kotti S, Brunel N, Ritz B, Leclercq F, Tabone X, Drouet E, Mulak G, Danchin N, Simon T Tags: J Clin Endocrinol Metab Source Type: research